Cargando…
Establishment of an Ex Vivo Tissue Culture Model for Evaluation of Antitumor Efficacy in Clear Cell Renal Cell Carcinoma
There are many potential immunotherapeutic targets for cancer immunotherapy, which should be assessed for efficacy before they enter clinical trials. Here we established an ex vivo cultured patient-derived tumor tissue model to evaluate antitumor effectiveness of one VISTA inhibitor, given that our...
Autores principales: | Hong, Shanjuan, Yuan, Qing, Xia, Haizhui, Dou, Yuan, Sun, Tiantian, Xie, Tian, Zhang, Zhiyin, He, Wei, Dong, Chen, Lu, Jian, Guo, Li, Ni, Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019348/ https://www.ncbi.nlm.nih.gov/pubmed/35463322 http://dx.doi.org/10.3389/fonc.2022.851191 |
Ejemplares similares
-
Analysis of VISTA expression and function in renal cell carcinoma highlights VISTA as a potential target for immunotherapy
por: Hong, Shanjuan, et al.
Publicado: (2019) -
KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma
por: Zheng, Jing-min, et al.
Publicado: (2021) -
Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma
por: Yu, Mengxue, et al.
Publicado: (2023) -
A Metastasis-Related lncRNA Signature Correlates With the Prognosis in Clear Cell Renal Cell Carcinoma
por: Dou, Qian, et al.
Publicado: (2021) -
Downregulation of METTL7B Inhibits Proliferation of Human Clear Cell Renal Cancer Cells In Vivo and In Vitro
por: Li, Wei, et al.
Publicado: (2021)